GCC 1366: Anti-Proliferative Response to NeoAdjuvant AIs in Overweight and Obese Patients
University of Maryland, Baltimore
University of Maryland, Baltimore
Cancer Trials Ireland
Genmab
Conjupro Biotherapeutics, Inc.
Spanish Breast Cancer Research Group
Criterium, Inc.
Centre Oscar Lambret
Centre Oscar Lambret
Centre Oscar Lambret
Centre Oscar Lambret
Allarity Therapeutics
Thomas Jefferson University
Penn State University
Medical University of South Carolina
Ramsay Générale de Santé
Mayo Clinic
Dana-Farber Cancer Institute
Baylor College of Medicine
M.D. Anderson Cancer Center
Stanford University
University of Virginia
AHS Cancer Control Alberta
Mayo Clinic
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Takeda
Fusion Pharmaceuticals Inc.
Fundacio Clinic Barcelona
University Hospital, Grenoble
University of Chicago
Thomas Jefferson University
Stanford University
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Spanish Breast Cancer Research Group
Ottawa Hospital Research Institute
Gustave Roussy, Cancer Campus, Grand Paris
Sanofi
Bolt Biotherapeutics, Inc.
Pfizer
Taiho Oncology, Inc.
University of Southern California
Nuvation Bio Inc.
Tempus AI
Incyte Corporation
Institut Bergonié
Actym Therapeutics, Inc.
Taiho Oncology, Inc.
Novartis
Zenith Epigenetics
Centre Francois Baclesse